all women in the study underwent placement of the levonorgestrel IUS in an open-label fashion, outcomes were compared before and after placement.

all women in the study underwent placement of the levonorgestrel IUS in an open-label fashion, outcomes were compared before and after placement.
levonorgestrel IUS: placement of levonorgestrel intrauterine system

Levonorgestrel IUS

Sex: Female, Male

Region of Enrollment

The outcome measure is designed to examine whether participants will experience subtherapeutic or toxic serum trough level of lamotrigine after IUD insertion.

There was one group in this pilot study. All women received the LNG IUS.

Women With Epilepsy Receiving the LNG IUS

Percent of Participants That Experienced Clinically Meaningful Change in Lamotrigine Level

The outcome measure is designed to examine whether participants will experience subtherapeutic or toxic serum trough level of levetiracetam after IUD insertion.

Percent of Participants That Experienced Clinically Meaningful Change in Levetiracetam Level

The outcome measure is designed to examine whether participants will experience subtherapeutic or toxic serum trough level of oxcarbazepine after IUD insertion.

Percent of Participants That Experienced Clinically Meaningful Change in Oxcarbazepine Level

Number of participants with increased, unchanged or decreased mean monthly seizure frequency.

Change in Seizure Frequency

Women continuing the IUD for contraception at 6 months

Number of Participants Continuing With IUD

Overall Study

Anne Davis, MD

Epilepsy

Contraception

placement of levonorgestrel intrauterine system

levonorgestrel IUS

Columbia University

Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users

Women With Epilepsy: a Pilot Study of Pharmacokinetic and Pharmacodynamic Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users

Anne Davis

Associate Professor of Clinical Obstetrics and Gynecology

Bayer

Inj. Ceftriaxone and other micronutrients will be given to children at the day-care clinic from 8:00 a.m. to 5:00 p.m. daily.

Hospital management: all children admitted at the hospital will be managed with injection Ceftriaxone and other micronutrients for the total duration of hospitalization as per approved protocol.

Malnutrition

Pneumonia

Day-care clinic

Inj. Ceftriaxone and other micronutrients will be given to children at the hospital from admission till discharge.

Hospital Management

International Centre for Diarrhoeal Disease Research Bangladesh

Trial in Childhood Pneumonia With Malnutrition

Randomized, Controlled Clinical Trial of Day-care Based and Hospitalized Management of Severe and Very Severe Pneumonia, With Severe Malnutrition, With/Without Associated Co-morbidities in Children

chlamydia infections/ataque epiléptico

Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users

Trial in Childhood Pneumonia With Malnutrition

Randomized Controlled Trial (RCT) in Children With Severe Pneumonia

La base de datos de hierbas medicinales más completa respaldada por la ciencia